Cargando…

Cytomegalovirus-Specific T Cells from Third-Party Donors Successfully Treated Refractory Cytomegalovirus Retinitis after Unrelated Umbilical Cord Blood Transplantation

Umbilical cord blood (UCB) transplants (UCBTs) are becoming increasingly common in the treatment of a variety of hematologic and nonhematologic conditions. The T cells from UCB are naïve T cells, which have not yet been exposed to antigens and therefore do not contain T cells with specific immune fu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Na, Sun, Guangyu, Zhu, Lihua, Ding, Kang, Liu, Huilan, Zhu, Xiaoyu, Tang, Baolin, Yao, Wen, Wan, Xiang, Geng, Liangquan, Qiang, Ping, Song, Kaidi, Zheng, Changcheng, Sun, Zimin, Tong, Juan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681565/ https://www.ncbi.nlm.nih.gov/pubmed/36426138 http://dx.doi.org/10.1155/2022/6285510

Ejemplares similares

Transplants of unrelated cord blood or sibling allogeneic peripheral blood stem cells/bone marrow in adolescent and young adults with chronic myeloid leukemia: comparable outcomes but better chronic GVHD-free and relapse-free survival among survivors with cord blood
por: Zheng, Changcheng, et al.
Publicado: (2017)

Third-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplant
por: Prockop, Susan E., et al.
Publicado: (2023)

Umbilical cord blood transplantation can overcome the poor prognosis of KMT2A-MLLT3 acute myeloid leukemia and can lead to good GVHD-free/relapse-free survival
por: Tong, Juan, et al.
Publicado: (2021)

Foscarnet treatment of cytomegalovirus infection in haploidentical or unrelated donor transplants
por: Metafuni, Elisabetta, et al.
Publicado: (2018)

Donor KIR3DL1/receptor HLA-Bw4-80I Combination Reduces Acute Leukemia Relapse after Umbilical Cord Blood Transplantation without in Vitro T-cell Depletion
por: Fang, Xinchen, et al.
Publicado: (2021)

The incidence, risk factors and outcomes of early bloodstream infection in patients with malignant hematologic disease after unrelated cord blood transplantation: a retrospective study
por: Ge, Jing, et al.
Publicado: (2018)

Treating Relapsed/Refractory Acute Myeloid Leukemia with Chidamide, Fludarabine, Cytarabine and Granulocyte-Colony Stimulating Factor with Subsequent Bridging to Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation
por: Yao, Wen, et al.
Publicado: (2022)

Unrelated cord blood transplantation vs. HLA-matched sibling transplantation for adults with B-cell acute lymphoblastic leukemia in complete remission: superior OS for patients with long-term survival
por: Sun, Guangyu, et al.
Publicado: (2022)

Extensively drug-resistant Gram-negative bacterial bloodstream infection in hematological disease
por: Zhou, Li, et al.
Publicado: (2019)

Impact of Consolidative Unrelated Cord Blood Transplantation on Clinical Outcomes of Patients With Relapsed/Refractory Acute B Lymphoblastic Leukemia Entering Remission Following CD19 Chimeric Antigen Receptor T Cells
por: Xu, Qianwen, et al.
Publicado: (2022)

Umbilical cord blood transplantation: Still growing and improving
por: Zhu, Xiaoyu, et al.
Publicado: (2021)

A comparative study of idarubicin 12 mg/m(2) and 8 mg/m(2) combined with cytarabine as the first induction regimen for adult acute myeloid leukemia patients
por: Zhou, Li, et al.
Publicado: (2016)

Efficacy of Venetoclax Combined with Decitabine-Based Treatment for Heavily Pre-Treated Relapsed or Refractory AML Patients in a Real-World Setting
por: Tong, Juan, et al.
Publicado: (2021)

Dynamic comparison of early immune reactions and immune cell reconstitution after umbilical cord blood transplantation and peripheral blood stem cell transplantation
por: Zhao, Xuxu, et al.
Publicado: (2023)

The blood donor: detection and magnitude of cytomegalovirus carrier states and the prevalence of cytomegalovirus antibody.
por: Bayer, W. L., et al.
Publicado: (1976)

Impact Of ELN Risk Stratification, Induction Chemotherapy Regimens And Hematopoietic Stem Cell Transplantation On Outcomes In Hyperleukocytic Acute Myeloid Leukemia With Initial White Blood Cell Count More Than 100 × 10(9)/L
por: Feng, Shanglong, et al.
Publicado: (2019)

An infant with refractory cytomegalovirus‐induced thrombocytopenia
por: Uemura, Suguru, et al.
Publicado: (2019)

Donor-derived cytomegalovirus-cytotoxic T lymphocytes and leflunomide successfully control refractory cytomegalovirus infections and disease of multiple sites after allogeneic-hematopoietic stem cell transplantation: A case report
por: Su, Nan, et al.
Publicado: (2022)

Umbilical cord blood versus unrelated donor transplantation in adults with primary refractory or relapsed acute myeloid leukemia: a report from Eurocord, the Acute Leukemia Working Party and the Cord Blood Committee of the Cellular Therapy and Immunobiology Working Party of the EBMT
por: Baron, Frédéric, et al.
Publicado: (2019)

Quantification of Active and Latent Form of Human Cytomegalovirus Infection in Umbilical Cord Blood Donors by Real-Time PCR
por: Abedi, E., et al.
Publicado: (2017)

Refining eligibility criteria of unit selection for myeloablative cord blood transplantation in acute leukemia: Real‐world experience of a referral center
por: Sun, Zimin, et al.
Publicado: (2023)

Standard-Intensity Induction and Intermediate/High-Dose Cytarabine Consolidation Can Improve Survival for Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia: A Retrospective Cohort Study
por: Wang, Li, et al.
Publicado: (2022)

Withdrawal: Down‐regulation of circRNA_0000143 regulates miR‐142‐3p/GRα axis to facilitate the progression of T‐ALL
por: Tong, Juan, et al.
Publicado: (2023)

Comparison of two methods used for monitoring low-copy cytomegalovirus infection in a patient with chronic myeloid leukemia after unrelated umbilical cord blood transplantation
por: Dzieciątkowski, Tomasz, et al.
Publicado: (2007)

Cytomegalovirus in donors for fecal microbiota transplantation, the phantom menace?
por: Galpérine, Tatiana, et al.
Publicado: (2023)

Sensitivity of the Cytomegalovirus Antigenemia Assay to Diagnose Cytomegalovirus Retinitis
por: Hong, Sun In, et al.
Publicado: (2016)

Infectious Complications after Umbilical Cord-Blood Transplantation from Unrelated Donors
por: Montoro, Juan, et al.
Publicado: (2016)

A predictive model combining clinical characteristics and nutritional risk factors for overall survival after umbilical cord blood transplantation
por: Tu, Meijuan, et al.
Publicado: (2023)

Cytomegalovirus Enterocolitis in a Patient with Refractory Immune-Related Colitis
por: Furuta, Yoki, et al.
Publicado: (2020)

Comparison of matched sibling donors versus unrelated donors in allogeneic stem cell transplantation for primary refractory acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT
por: Brissot, Eolia, et al.
Publicado: (2017)

Advances and Challenges in Cytomegalovirus Detection Methods for Liver Transplant Donors
por: Li, Xiaoping, et al.
Publicado: (2023)

Cytomegalovirus-specific neutralizing antibodies effectively prevent uncontrolled infection after allogeneic hematopoietic stem cell transplantation
por: Wang, Huiru, et al.
Publicado: (2022)

Extraordinarily elevated CD33 expression in CD56(+)CD3(–) cells in the bone marrow of a patient with relapsed acute myeloid leukemia: a case report
por: Wang, Dongyao, et al.
Publicado: (2021)

Inflammatory monocytes promote pre-engraftment syndrome and tocilizumab can therapeutically limit pathology in patients
por: Jin, Linlin, et al.
Publicado: (2021)

Cytomegalovirus Treatment
por: Tan, Ban Hock
Publicado: (2014)

Cytomegalovirus induced refractory TTP in an immunocompetent individual: a case report
por: Boteju, Medhini, et al.
Publicado: (2019)

Response to “Cytomegalovirus Enterocolitis in a Patient with Refractory Immune-Related Colitis”
por: van Turenhout, Sietze, et al.
Publicado: (2021)

All-trans retinoic acid 45 mg/m(2) is superior to 25 mg/m(2) as the first induction regimen for the treatment of acute promyelocytic leukaemia: a retrospective analysis in a real-world clinical setting
por: Zhang, Xinhui, et al.
Publicado: (2021)

Seroprevalence of cytomegalovirus in donors & opportunistic viral infections in liver transplant recipients
por: Varghese, Joy, et al.
Publicado: (2017)

Immunohistochemistry Staining-Proven Cytomegalovirus Colitis in Living Donor Liver Transplantation
por: Lin, Shu-Hsien, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ol97obkqvlgjqej2vgbg79mtjj